e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Natera, Inc. - Common Stock
(NQ:
NTRA
)
309.93
-0.85 (-0.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Natera, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference
↗
August 15, 2026
Natera (NASDAQ:NTRA) Chief Financial Officer Mike Brophy said the company delivered strong second-quarter momentum across its women’s health, oncology and organ health businesses, citing record...
Via
MarketBeat
Natera (NTRA) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Oncology volumes jumped 57.2% on MRD adoption gains.
Via
The Motley Fool
Topics
Earnings
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call
August 13, 2026
Natera’s second quarter results were positively received by the market, driven by robust sales volume growth and ongoing momentum in both established and eme...
Via
StockStory
Topics
Earnings
Natera (NASDAQ:NTRA) Beats Q2 Estimates, Raises Full-Year Revenue Guidance
↗
August 06, 2026
Via
Chartmill
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
↗
August 10, 2026
Moshkevich's non-discretionary sale was executed to cover tax withholding on vesting RSUs under a Rule 10b5-1 plan.
Via
The Motley Fool
Topics
Regulatory Compliance
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
↗
August 10, 2026
This sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Via
The Motley Fool
Topics
Regulatory Compliance
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
↗
August 10, 2026
This sale was non-discretionary and executed under a Rule 10b5-1 plan to cover tax withholding from RSU vesting.
Via
The Motley Fool
Topics
Regulatory Compliance
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It
↗
August 10, 2026
This was a non-discretionary sale to cover tax withholding on vesting equity awards under a Rule 10b5-1 plan.
Via
The Motley Fool
Topics
Regulatory Compliance
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know
↗
August 10, 2026
Sheena executed 9,150 shares under a pre-established trading plan adopted in December 2025.
Via
The Motley Fool
Topics
Regulatory Compliance
Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead.
↗
August 08, 2026
Druckenmiller only owns one "Magnificent Seven" stock.
Via
The Motley Fool
Topics
Artificial Intelligence
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth
August 07, 2026
Genetic testing company Natera (NASDAQ:NTRA) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 37.7% year on year to $752.8...
Via
StockStory
Natera Q2 Earnings Call Highlights
↗
August 07, 2026
Natera (NASDAQ:NTRA) reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth...
Via
MarketBeat
Topics
Earnings
3 Growth Stocks with All-Star Potential
August 07, 2026
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...
Via
StockStory
Topics
Energy
Natera (NASDAQ:NTRA) Reports Strong Q2 CY2026, Stock Jumps 16.3%
August 06, 2026
Genetic testing company Natera (NASDAQ:NTRA) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 37.7% year on year to $752.8 mi...
Via
StockStory
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years
↗
August 05, 2026
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 24.85% on an annualized basis producing an average annual return of 38.28%. Currently, Natera has a market capitalization of...
Via
Benzinga
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings
August 04, 2026
Genetic testing company Natera (NASDAQ:NTRA) will be announcing earnings results this Thursday afternoon. Here’s what investors should know. Natera beat anal...
Via
StockStory
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy?
↗
August 04, 2026
The company has made massive strides in medical diagnostics and is growing at a rapid clip.
Via
The Motley Fool
Topics
Intellectual Property
1 Unpopular Stock That Deserves Some Love and 2 We Question
July 27, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
3 Reasons We’re Fans of Natera (NTRA)
July 24, 2026
Natera has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.1% to $263.44 per...
Via
StockStory
Topics
Stocks
3 Market-Beating Stocks Worth Your Attention
July 22, 2026
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that ca...
Via
StockStory
Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves.
↗
July 16, 2026
It may not be a familiar name, but Natera has provided better returns than Nvidia over the past 12 months.
Via
The Motley Fool
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
July 15, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Natera (NASDAQ:NTRA) and its ...
Via
StockStory
Topics
Artificial Intelligence
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off
July 10, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via
StockStory
Why Natera (NTRA) Stock Is Up Today
June 24, 2026
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 7.7% in the morning session after the company announced its Signatera test rece...
Via
StockStory
Topics
Artificial Intelligence
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
June 16, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via
StockStory
1 Cash-Heavy Stock on Our Buy List and 2 We Avoid
June 15, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via
StockStory
Topics
Retirement
2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down
June 08, 2026
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Via
StockStory
Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia)
↗
June 03, 2026
The famous hedge fund manager seems to have found a hidden gem outside of the market's most popular stock picks.
Via
The Motley Fool
NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million
↗
May 30, 2026
MercadoLibre delivers e-commerce and fintech solutions across Latin America, leveraging an integrated digital ecosystem for regional growth.
Via
The Motley Fool
Topics
Regulatory Compliance
1 Mid-Cap Stock with Exciting Potential and 2 That Underwhelm
May 19, 2026
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.